PHILADELPHIA (July 16, 2019) – Inflammation plays an instrumental role in tumor development, affecting the tumor microenvironment, immune responses, and tumor growth and spread. This critical role in cancer may be getting a bit lost.
PHILADELPHIA (July 5, 2019) — The biliary microbiome was altered in patients who received neoadjuvant therapy prior to undergoing surgery for pancreatic cancer, according to new research from Fox Chase Cancer Center.
PHILADELPHIA (July 3, 2019) – Fox Chase Cancer Center is pleased to announce the hiring of James M. Martin, MD, who will join the faculty as assistant professor in the Hematology and Bone Marrow Transplant Programs within the Department of Hematology/Oncology.
PHILADELPHIA (June 28, 2019) – Fox Chase Cancer Center announces the hiring of Nicholas Mackrides, MD, who will join the faculty as a clinical instructor in the Department of Pathology.
PHILADELPHIA (June 27, 2019) – Researchers at Fox Chase Cancer Center have developed a new classification scheme and nomenclature for the structural states of protein kinases, which play an important role in signaling pathways and can be targeted by cancer treatments.
PHILADELPHIA (June 26, 2019) – Researchers at Fox Chase Cancer Center have compared the genomic landscape of CRC in younger patients to older patients. Their analysis found differences in molecular carcinogenesis and may impact treatment decision-making.
PHILADELPHIA (June 19, 2019)— Mark Sobczak, MD, FACR, clinical director in the Department of Radiation Oncology at Fox Chase Cancer Center, was selected as a 2019 Fellow of the American College of Radiology (ACR).